牛宝体育app下载-APP免费下载

90 press releases in total

2026

Jun 18, 2026

Jacobio Pharma Engages Pharmaron to Initiate Manufacturing of JAB-23E73 for Registrational Clinical Trials

[More]
May 15, 2026

Jacobio Pharma’s BET Inhibitor JAB-8263 Approved for Phase IIa Clinical Trial in Rheumatoid Arthritis in China

[More]
May 13, 2026

Jacobio Pharma Appoints Dr. Yan Chen as Vice President of CMC to Accelerate Development of Its Small Molecule and xADC Platforms

[More]
May 11, 2026

Jacobio-Licensed KRAS G12C and SHP2 Inhibitor Combination Receives Breakthrough Therapy Designation in China

[More]
Mar 30, 2026

Jacobio Pharma Receives US$100 Million Upfront Payment from AstraZeneca

[More]
Mar 11, 2026

Jacobio Announces 2025 Annual Results

[More]

2025

Dec 21, 2025

Jacobio Pharma Enters Global Exclusive License Agreement with AstraZeneca for Pan-KRAS Inhibitor JAB-23E73

[More]
Dec 5, 2025

Glecirasib Colorectal Cancer Data Published in The Lancet Gastroenterology & Hepatology

[More]
Dec 1, 2025

Jacobio’s KRAS G12C and SHP2 Combination Therapy Published in The Lancet Respiratory Medicine

[More]
Nov 13, 2025

Jacobio Pharma Announces Establishment of Co-CEO System

[More]
Nov 11, 2025

Jacobio Included in the MSCI China All Shares Small Cap Index

[More]
Oct 24, 2025

Jacobio Presents Pre-Clinical Data of Pan-KRAS Inhibitor (JAB-23E73) at AACR-NCI-EORTC International Conference

[More]
Oct 15, 2025

Jacobio Pharma Announces Strategic Partnership with Oceanpine Capital to Focus on Core Oncology Pipeline

[More]
Aug 30, 2025

Jacobio Pharma Announces 2025 Interim Results

[More]
Jul 2, 2025

Jacobio Pharma Completes First Patient Dosage of Pan-KRAS Inhibitor in U.S.

[More]
May 22, 2025

Jacobio’s KRAS G12C Inhibitor Glecirasib Approved for Market Launch

[More]
May 9, 2025

SHP2 Inhibitor Sitneprotafib Combination Therapy Data Published in Academic Journal

[More]
Mar 20, 2025

Jacobio Pharma Announces 2024 Annual Results

[More]
Jan 7, 2025

The Registrational Clinical Data of Glecirasib was Published in Nature Medicine

[More]

2024

Dec 10, 2024

Jacobio Pharma Presented preliminary Data on BET Inhibitor for Myelofibrosis at 2024 ASH

[More]

Pages